Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 USD | +3.34% | -10.05% | -61.32% |
Apr. 26 | AbbVie raises annual profit forecast on strong Skyrizi sales | RE |
Apr. 12 | Revance Therapeutics, Inc. to Present New DAXXIFY Data at the American Academy of Neurology 2024 Annual Meeting | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 4.130 | 5.190 | 10.60 |
Spread/Res. | -17.68% | -34.49% | -67.92% |
Spread/Supp. | +3.34% | +3.34% | +46.55% |
Support | 3.290 | 3.290 | 2.320 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- RVNC Stock
- Charts Revance Therapeutics, Inc.